Recent evidence has shown that increased levels of AKT2, upregulated in dysfunctional RPE and dry AMD patients [6], impair TFEB/TFE3-dependent lysosomal and mitochondrial function in an iPSC-derived dry AMD model. Here, AKT2 is linked to dry age related macular degeneration.